Wells Fargo & Company »

Crinetics Pharmaceuticals In shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2M 69k 46.81
2023-12-31 $745k 21k 35.58
2023-09-30 $1.5M 52k 29.74
2023-06-30 $795k 44k 18.02
2022-12-31 $7.6k 417 18.30
2022-09-30 $21k 976 21.16
2022-06-30 $27k 1.5k 17.62
2022-03-31 $135k 6.2k 21.92
2021-12-31 $0 22k 0.00
2021-03-31 $79k 5.2k 15.21
2020-12-31 $327k 23k 14.10
2020-09-30 $297k 20k 14.97
2020-06-30 $355k 20k 17.53
2020-03-31 $99k 6.8k 14.65
2019-12-31 $231k 9.3k 24.89
2019-09-30 $351k 23k 15.06
2019-06-30 $505k 20k 25.00
2019-03-31 $233k 10k 22.84
2018-12-31 $304k 10k 30.09
2018-09-30 $97k 3.4k 28.66